ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for people who are considering taking part in clinical trials and would like to find out more about what’s involved, why clinical trials are important and what the benefits of taking part in trials are. You can also find out about current clinical trials going on in ICTU and how to get involved.

Clinical Trials Search

OR

CurrentAll Trials

VANISH

Trial Details

  • Trial statusAnalysis
  • Study email contactVANISH@imperial.ac.uk
  • Chief InvestigatorDr Anthony Gordon
  • Project managerNeeraja Thirunavukkarasu
  • SponsorImperial College London
  • ISRCTN numberISRCTN20769191
  • PhaseIV

Vasopressin vs Noradrenaline as Initial therapy in Septic Shock

Design and Objective

The primary objectives are: 1. To test if vasopressin reduces renal dysfunction compared to noradrenaline when used as the initial vasopressor in the management of adult patients who have septic shock. 2. To test if there is an interaction between vasopressin and corticosteroids when used in the management of septic shock?

Key inclusion criteria

- Hypotension despite adequate intravenous fluid resuscitation AND two of the following: - Fever (>38 C) or hypothermia (<36 C) - Tachycardia (heart rate >90 bpm) - Tachypnoea (respiratory rate >20 breaths per min or PaCO2 <4.3 kPa) or on mechanical ventilation - Abnormal leukocyte count (>12,000/<4000 cells mm3)

Study Disclaimer Statement